The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease
Impact of Age on Use of Neoadjuvant Chemoimmunotherapyand Outcomes for Patients with Triple‑Negative Breast Cancer
36:12
Mastologia
Podemos prescrever o Keynote 522 para mulheres idosas com tumor TN ? / ctDNA: novo radar de doença residual no câncer de mama
Podcast
09/04/2026
05:00
Português
37:32
Mastologia
“Scout” bem, qual será a melhor técnica para marcar Tumores upfront e Linfonodo para investigação pós QTNeo? (AXSANA TRIAL) / IA Histopatológica x Oncotype DX: Começo do fim?
Podcast
02/04/2026
05:00
Português
Deep learning on histopathological images to predict breastcancer recurrence risk and chemotherapy benefit: a multicentre, model development and validation study
Marking Techniques for Target Lymph Nodesin Node-Positive Breast Cancer Treated With NeoadjuvantTherapy in the AXSANA/EUBREAST-03/AGO-B-053 Study
Vaginal tamoxifen – A potential treatment option for vaginal atrophysymptoms in postmenopausal women who cannot use estrogen
33:22
Mastologia
Tamoxifen vaginal funciona? Uma Prova de Conceito e Da teoria à prática: GLP-1 R. Agonista em câncer de mama
Podcast
26/03/2026
05:00
Português
Weight Loss Patterns and Clinical Outcomes ofGLP1 Receptor Agonists in Breast Cancer Survivors
Obesity and Cancer A Translational Science Review
CancerVIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor–Positive/HER22/ PIK3CA Wild-Type Advanced Breast Cancer
Is Lobular Histology a Predictor of Sentinel Node Positivity in Early Breast Cancer? An Integrated Analysis of Histological Subtype and Preoperative Imaging





